February 01, 2015 9:24 PM ET


Company Overview of Peloton Therapeutics, Inc.

Executive Profile

Timothy W. Kutzkey Ph.D.

Acting Chief Executive Officer and Director, Peloton Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships


Dr. Timothy W. Kutzkey, also known as Tim, Ph.D. serves as President at Neurona Therapeutics Inc. Mr. Kutzkey is a Partner of The Column Group LLC. He joined The Column Group in 2007 and has since contributed to the conception, formation, and management of many of The Column Group's portfolio companies. Dr. Kutzkey is also the Founder of Nurix, Inc. He serves as a Board Observer at Igenica. He serves as Acting Chief Executive Officer of Peloton Therapeutics, Inc. He ...

Corporate Headquarters

2330 Inwood Road
Dallas, Texas 75235-7323

United States

Phone: 972-629-4100
Fax: --

Board Members Memberships

Acting Chief Executive Officer and Director
Founder and Director
President and Director


Unknown/Other Education
Stanford University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Peloton Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.